• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm.

作者信息

Liu Ying, Derkach Andriy, Lewis Natasha, Zhu Menglei, Zhang Yanming, Arcila Maria, Salles Gilles, Dogan Ahmet, Xiao Wenbin

机构信息

Department of Pathology and Laboratory Medicine, Hematopathology Service; Department of Pathology and Laboratory Medicine, Molecular Diagnostic Service.

Department of Epidemiology and Biostatistics.

出版信息

Haematologica. 2023 Mar 1;108(3):917-922. doi: 10.3324/haematol.2022.281724.

DOI:10.3324/haematol.2022.281724
PMID:36384248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9973483/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddf/9973483/1000624ac792/108917.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddf/9973483/290a3a428712/108917.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddf/9973483/1000624ac792/108917.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddf/9973483/290a3a428712/108917.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ddf/9973483/1000624ac792/108917.fig2.jpg

相似文献

1
Clonal hematopoiesis in diffuse large B-cell lymphoma: clinical impact and genetic relatedness to lymphoma and therapy-related myeloid neoplasm.弥漫性大B细胞淋巴瘤中的克隆性造血：对临床的影响以及与淋巴瘤和治疗相关髓系肿瘤的遗传关联性
Haematologica. 2023 Mar 1;108(3):917-922. doi: 10.3324/haematol.2022.281724.
2
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective.从RUNX1角度看髓系肿瘤与克隆性造血
Leukemia. 2022 May;36(5):1203-1214. doi: 10.1038/s41375-022-01548-7. Epub 2022 Mar 30.
3
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.淋巴样克隆性造血：对恶性肿瘤、免疫和治疗的影响。
Blood Cancer J. 2023 Jan 4;13(1):5. doi: 10.1038/s41408-022-00773-8.
4
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.克隆性造血在自体造血干细胞移植后治疗相关髓系肿瘤中的作用。
Ann Hematol. 2022 Jun;101(6):1227-1237. doi: 10.1007/s00277-022-04806-x. Epub 2022 Apr 5.
5
Clonal hematopoiesis in the setting of hematopoietic cell transplantation.造血干细胞移植背景下的克隆性造血。
Semin Hematol. 2024 Feb;61(1):9-15. doi: 10.1053/j.seminhematol.2024.01.011. Epub 2024 Feb 1.
6
Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.诊断挑战与临床困境：克隆性造血的广泛影响
Clin Chem. 2021 Aug 5;67(8):1062-1070. doi: 10.1093/clinchem/hvab105.
7
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis.一名患有难治性弥漫性大B细胞淋巴瘤且存在克隆性造血的患者在接受抗CD19嵌合抗原受体T细胞输注后不久发生急性髓系白血病。
Haematologica. 2023 Jan 1;108(1):290-294. doi: 10.3324/haematol.2022.281351.
8
Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?克隆性造血的临床表现：SF3B1 突变 MDS 教会了我们什么？
Semin Hematol. 2022 Jul;59(3):150-155. doi: 10.1053/j.seminhematol.2022.08.002. Epub 2022 Aug 11.
9
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.解析经典霍奇金淋巴瘤患者组织中的克隆性造血
Blood Cancer Discov. 2021 May;2(3):216-225. doi: 10.1158/2643-3230.BCD-20-0203. Epub 2021 Apr 10.
10
Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.探讨不定潜能克隆性造血、髓系恶性肿瘤与动脉粥样硬化之间的关联。
Methods Mol Biol. 2022;2419:73-88. doi: 10.1007/978-1-0716-1924-7_5.

引用本文的文献

1
Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation.自体造血细胞移植后克隆性造血与非髓系后续恶性肿瘤风险
J Natl Cancer Inst. 2025 Sep 1;117(9):1925-1933. doi: 10.1093/jnci/djaf181.
2
Mutation as a Distinct Feature of Myeloid Neoplasms in B-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis.B细胞非霍奇金淋巴瘤患者髓系肿瘤的独特特征——突变：一项回顾性分析
Cancers (Basel). 2025 Mar 31;17(7):1185. doi: 10.3390/cancers17071185.
3
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for Lymphoma.

本文引用的文献

1
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma.克隆性造血与 axicabtagene ciloleucel 治疗大 B 细胞淋巴瘤时严重神经毒性风险增加相关。
Blood Cancer Discov. 2022 Sep 6;3(5):385-393. doi: 10.1158/2643-3230.BCD-21-0177.
2
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.解析经典霍奇金淋巴瘤患者组织中的克隆性造血
Blood Cancer Discov. 2021 May;2(3):216-225. doi: 10.1158/2643-3230.BCD-20-0203. Epub 2021 Apr 10.
3
Absence of a common founder mutation in patients with cooccurring myelodysplastic syndrome and plasma cell disorder.
淋巴瘤自体造血细胞移植后的克隆性造血与心力衰竭风险
JACC CardioOncol. 2024 Dec 3;7(1):20-33. doi: 10.1016/j.jaccao.2024.10.006. eCollection 2025 Jan.
4
Distinct landscape and clinical implications of therapy-related clonal hematopoiesis.治疗相关的克隆性造血的独特景观和临床意义。
J Clin Invest. 2024 Oct 1;134(19):e180069. doi: 10.1172/JCI180069.
5
Epidemiology and etiology of diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤的流行病学与病因学
Semin Hematol. 2023 Nov;60(5):255-266. doi: 10.1053/j.seminhematol.2023.11.004. Epub 2023 Nov 27.
6
TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia.TP53 突变的骨髓增生异常综合征和急性髓系白血病。
Mediterr J Hematol Infect Dis. 2023 Jul 1;15(1):e2023038. doi: 10.4084/MJHID.2023.038. eCollection 2023.
同时患有骨髓增生异常综合征和浆细胞疾病的患者中不存在共同的奠基者突变。
Blood. 2021 Mar 4;137(9):1260-1263. doi: 10.1182/blood.2020007555.
4
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers.健康志愿者血液和骨髓中克隆性造血的高患病率。
Blood Adv. 2020 Aug 11;4(15):3550-3557. doi: 10.1182/bloodadvances.2020001582.
5
Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome.高级别B细胞淋巴瘤患者的克隆性造血与较差的预后相关。
Am J Hematol. 2020 Oct;95(10):E287-E289. doi: 10.1002/ajh.25927. Epub 2020 Aug 12.
6
TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis.TET2缺陷会重编程生发中心B细胞的表观基因组，并使与淋巴瘤发生相关的基因沉默。
Sci Adv. 2020 Jun 17;6(25):eaay5872. doi: 10.1126/sciadv.aay5872. eCollection 2020 Jun.
7
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms.血管免疫母细胞性 T 细胞淋巴瘤中克隆性造血与向髓系肿瘤分化的演进。
Blood Adv. 2020 May 26;4(10):2261-2271. doi: 10.1182/bloodadvances.2020001636.
8
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.淋巴瘤患者接受 ASCT 后克隆性造血的临床影响：一项全国基于人群的队列研究。
Leukemia. 2020 Dec;34(12):3256-3268. doi: 10.1038/s41375-020-0795-z. Epub 2020 Mar 20.
9
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.套细胞淋巴瘤患者的克隆性造血从预处理克隆演变而来，并在化疗结束后稳定下来。
Blood. 2020 May 28;135(22):2000-2004. doi: 10.1182/blood.2019003539.
10
Clinical consequences of clonal hematopoiesis of indeterminate potential.不确定潜能的克隆性造血的临床后果。
Blood Adv. 2018 Nov 27;2(22):3404-3410. doi: 10.1182/bloodadvances.2018020222.